TFGT
KYNB

TS Financial Group (TSFG)’s Kyntra Bio KYNB Stock Holding History

TS Financial Group (TSFG)’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6
Closed -$1K – 896
2021
Q3 		$1K Buy
6
+5
+500% +$1.77K ﹤0.01% 809
2021
Q2 		$6K Buy
+1
New +$576 ﹤0.01% 631

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

TS Financial Group (TSFG)'s KYNB Position: Q4 2021 in Review

TS Financial Group (TSFG) sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 6 shares — an estimated $2K sold.

TS Financial Group (TSFG) first reported a position in KYNB in Q2 2021 and held it in 2 quarters. The position peaked at $133K in Q2 2021. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

  • TS Financial Group (TSFG) reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 6 Kyntra Bio shares in Q4 2021, an estimated $2K.
  • TS Financial Group (TSFG) first reported a position in Kyntra Bio in Q2 2021 and held it in 2 quarters.
  • TS Financial Group (TSFG)'s Kyntra Bio position peaked at $133K in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2021, filed 10 Feb 2022.